| Year |
Citation |
Score |
| 2014 |
Morales JK, Saleem SJ, Martin RK, Saunders BL, Barnstein BO, Faber TW, Pullen NA, Kolawole EM, Brooks KB, Norton SK, Sturgill J, Graham L, Bear HD, Urban JF, Lantz CS, et al. Myeloid-derived suppressor cells enhance IgE-mediated mast cell responses. Journal of Leukocyte Biology. 95: 643-50. PMID 24338630 DOI: 10.1189/Jlb.0913510 |
0.532 |
|
| 2012 |
Saleem SJ, Martin RK, Morales JK, Sturgill JL, Gibb DR, Graham L, Bear HD, Manjili MH, Ryan JJ, Conrad DH. Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity. Journal of Immunology (Baltimore, Md. : 1950). 189: 511-5. PMID 22706087 DOI: 10.4049/Jimmunol.1200647 |
0.619 |
|
| 2012 |
Pullen NA, Falanga YT, Morales JK, Ryan JJ. The Fyn-STAT5 Pathway: A New Frontier in IgE- and IgG-Mediated Mast Cell Signaling. Frontiers in Immunology. 3: 117. PMID 22593761 DOI: 10.3389/Fimmu.2012.00117 |
0.409 |
|
| 2010 |
Morales JK, Falanga YT, Depcrynski A, Fernando J, Ryan JJ. Mast cell homeostasis and the JAK-STAT pathway. Genes and Immunity. 11: 599-608. PMID 20535135 DOI: 10.1038/gene.2010.35 |
0.334 |
|
| 2010 |
Macey MR, Sturgill JL, Morales JK, Falanga YT, Morales J, Norton SK, Yerram N, Shim H, Fernando J, Gifillan AM, Gomez G, Schwartz L, Oskeritzian C, Spiegel S, Conrad D, et al. IL-4 and TGF-beta 1 counterbalance one another while regulating mast cell homeostasis. Journal of Immunology (Baltimore, Md. : 1950). 184: 4688-95. PMID 20304823 DOI: 10.4049/Jimmunol.0903477 |
0.417 |
|
| 2010 |
Oskeritzian CA, Price MM, Hait NC, Kapitonov D, Falanga YT, Morales JK, Ryan JJ, Milstien S, Spiegel S. Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema. The Journal of Experimental Medicine. 207: 465-74. PMID 20194630 DOI: 10.1084/Jem.20091513 |
0.392 |
|
| 2010 |
Morales JK, Kmieciak M, Knutson KL, Bear HD, Manjili MH. GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1-bone marrow progenitor cells into myeloid-derived suppressor cells Breast Cancer Research and Treatment. 123: 39-49. PMID 19898981 DOI: 10.1007/S10549-009-0622-8 |
0.671 |
|
| 2010 |
Ryan JJ, Morales JK, Falanga YT, Fernando JF, Macey MR. Mast Cell Regulation of the Immune Response: Erratum World Allergy Organization Journal. 3: 14. DOI: 10.1097/Wox.0B013E3181D1D60F |
0.436 |
|
| 2009 |
Ryan JJ, Morales JK, Falanga YT, Fernando JF, Macey MR. Mast cell regulation of the immune response. The World Allergy Organization Journal. 2: 224-32. PMID 23283207 DOI: 10.1097/Wox.0B013E3181C2A95E |
0.537 |
|
| 2009 |
Le HK, Graham L, Cha E, Morales JK, Manjili MH, Bear HD. Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice. International Immunopharmacology. 9: 900-9. PMID 19336265 DOI: 10.1016/j.intimp.2009.03.015 |
0.659 |
|
| 2009 |
Morales JK, Kmieciak M, Graham L, Feldmesser M, Bear HD, Manjili MH. Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells. Cancer Immunology, Immunotherapy : Cii. 58: 941-53. PMID 18979098 DOI: 10.1007/S00262-008-0609-Z |
0.674 |
|
| 2009 |
Habibi M, Kmieciak M, Graham L, Morales JK, Bear HD, Manjili MH. Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis. Breast Cancer Research and Treatment. 114: 423-31. PMID 18425677 DOI: 10.1007/S10549-008-0024-3 |
0.655 |
|
| 2008 |
Kmieciak M, Morales JK, Morales J, Bolesta E, Grimes M, Manjili MH. Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design. Cancer Immunology, Immunotherapy : Cii. 57: 1391-8. PMID 18278493 DOI: 10.1007/S00262-008-0475-8 |
0.641 |
|
| Show low-probability matches. |